Clinical trial

[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)

NCT02562989

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-10-19

PhasePHASE1

Study timeline

Study start (actual)2015-10-19Date precision: day

Registry last updated2018-09-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer's Diseaseunresolved

Amnestic Mild Cognitive Impairmentunresolved

Interventions

[18F]MK-6240, ~185 MBqDRUG

[18F]MK-6240, ~160 MBqDRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02562989 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.